The Cancer Letter

Inside information on cancer research and drug development

Vol.
37
No.
43
November 18, 2011Nov 18, 2011
Free
DOWNLOAD THE PDF

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

Industry Groups Lobby for Lower Standards for FDA Approval

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account